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Abstract
Background: Juvenile idiopathic arthritis (JIA) is a systemic chronic inflammatory disease. Studies using tissue Doppler
imaging (TDI) for the evaluation of cardiac functions of children with JIA are limited. Thus, this study was conducted to
evaluate Left ventricular function, left atrial mechanical functions and atrial electromechanical delay in JIA.
Methods: This study was carried out as a across sectional study. A total of 34 patients with active JIA and 34 controls
were included. Atrial electromechanical delay and left atrial (LA) mechanical functions in addition to systolic and
diastolic left ventricular (LV) functions were measured by using conventional echocardiography and TDI. Assessment of
disease activity was done using Juvenile arthritis disease activity score (JADAS-27).
Results: JIA patients had abnormal atrial electromechanical coupling as established from prolonged lateral mitral
annulus (PA lateral), septal mitral annulus (PA septum), inter-atrial and intra-atrial electromechanical delays compared
with healthy controls. Left ventricular filling abnormalities were found characterized by a reduced E/A ratio
(1.07 ± 0.56 vs. 1.48 ± 0.16, p = 0.01). E/Em was significantly higher in patients with JIA (7.58 ± 1.79 vs. 4.74 ± 1.
45, p = 0.003) denoting impaired diastolic function. Left atrial mechanical functions assessment showed significantly
decreased LA passive emptying fraction, increased LA active emptying fraction and LA total emptying volume in JIA
patients (p = 0.01, p = 0.01, p = 0.03 respectively).
Conclusion: Atrial electromechanical coupling intervals, and LA mechanical functions were impaired which can be
considered as an early form of subclinical cardiac involvement in JIA patients. Significant diastolic functional
abnormalities exist in JIA.
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Background
Juvenile idiopathic arthritis (JIA) is defined as ‘persistent
arthritis of unknown etiology that begins earlier than
16 years and persists for at least 6 weeks’ [1]. It affects
about 1 in 1,000 children worldwide and is the most
common cause of autoimmune musculoskeletal disor-
ders [2]. It represents up to 65% of arthritic diseases in
children and is one of the highest five chronic illnesses
in children [3]. Cardiac (pericardial, myocardial or endo-
cardial) involvements in JIA are usually subclinical.
However, the long-term risk, the clinical course and
prognosis of cardiac involvement in JIA is unclear [4].
Rhythm and conduction disturbances when manifested
are considered as a significant cause of cardiovascular
(CV) morbidity and mortality in patients with JIA [5].
Atrial fibrillation (AF) is the most common arrhythmia
of clinical significance [6].
Nowadays, it has been recognized that inflammation
plays a significant role in the pathogenesis of atrial fibril-
lation (AF) [7]. The risk of AF is increased in patients
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with rheumatic diseases such as rheumatoid arthritis,
systemic lupus erythematosus and psoriasis, which all
implicate systemic inflammation in their pathogenesis
[8]. However, the relationship between JIA and AF is not
yet obviously understood as in other rheumatic diseases.
Electrophysiological and electromechanical abnormal-
ities originating from conduction disturbances in the atria
are associated with an increased risk of AF [9, 10]. The
prolongation of intra- and interatrial electromechanical
delay and the non-uniform transmission of sinus impulses
are frequent electrophysiological features of the atria
predisposed to fibrillation [11]. Atrial electromechanical
delay may be measured using invasive and noninvasive
techniques. With recent developments in echocardio-
graphic techniques, Tissue Doppler imaging (TDI) has
become an alternative noninvasive method [9].
Tissue Doppler imaging (TDI) has been proved to
provide atrial conduction times, measurements of local
systolic and diastolic myocardial velocities as well as
detection of abnormalities of left ventricular diastolic
function [12, 13]. An increase in atrial electromechan-
ical delay duration measured with this method was
shown to be an independent variable for AF develop-
ment [9].
To the extent of our knowledge, the published studies
assessed left ventricular diastolic dysfunction by TDI
without assessing atrial electromechanical delay and LA
mechanical functions in JIA patients [14]. Therefore, this
study aimed at assessing atrial electromechanical coup-
ling, LA mechanical functions and subclinical LV systolic
and diastolic functions using tissue Doppler and correl-
ating atrial electromechanical delay to LA mechanical
functions, LV functions and disease activity in Suez
Canal area JIA patients.
Methods
This study was carried out as a cross sectional study.
Thirty-four active JIA patients with a mean age of
13.97 ± 4.77 years, fulfilling the revised criteria of the
International League of Associations for Rheumatol-
ogy (ILAR) [15] were enrolled for assessment at the
Pediatric, Cardiology and Physical Medicine, Rheuma-
tology and Rehabilitation departments as well as
Family Medicine Centers and Clinics affiliated to
Faculty of Medicine, Suez Canal University in Ismailia,
Suez and Port-Said governorates. In addition, age-gender
matched 34 healthy children attending the outpatients’
clinics for non-medical causes were randomly recruited to
the Study as control.
All study Children older than 16 years; children with
rheumatic or congenital heart disease, history of any
clinical evidence of coexisting cardiac disease, diabetes
mellitus, arrhythmia, valvular heart diseases or ischemic
heart diseases were excluded by history, physical
examination, chest radiography, Echocardiography and
standard 12-lead electrocardiography (ECG).
Prior to subject recruitment, the study protocol was
reviewed and approved by the research ethics committee
of the Faculty of Medicine, Suez Canal University, writ-
ten informed consents were obtained from all the
Parents or care givers. All procedures performed in
studies involving human participants were in accordance
with the ethical standards of the research ethics committee
of the Faculty of Medicine Suez Canal University and with
the 1964 Helsinki declaration and its later amendments.
We gathered information regarding patient character-
istics such as age, gender and disease duration. Growth
parameters measured were height (to nearest 0.5 cm via
Harpenden stadiometer), weight (to nearest 0.1 kg), and
body mass index (BMI) was calculated as weight (kg)/
height (m)2 [16]. All subjects were managed according
to the American College of Rheumatology (ACR) guide-
lines for the medical therapy of children with Juvenile
Idiopathic Arthritis [17].
Juvenile arthritis disease activity score (JADAS-27)
calculation
The JADAS-27 is calculated by summing the scores of
four core-set criteria [18]: 1) physician global rating of
overall disease activity, measured on a 10-cm horizontal
Visual Analog Scale (VAS) (0 = no activity; 10 =maximum
activity for both VAS); 2) parent/child ratings of well-being
and pain, assessed on a 10-cm horizontal VAS (0 = best;
10 = worst for both VAS); 3) number of active joints, de-
fined as joint swelling or limitation of movement accom-
panied by pain and tenderness, assessed in 27 joints; and
4) Westergren Erythrocyte Sedimentation Rate (ESR).
JADAS is scored on a continuous scale from 0–57.
JADAS-27 cut-off score is ≤2.7 for low disease activity and
≥6 for high disease activity [19, 20].
Transthoracic Echocardiographic (TTE) study
Transthoracic echocardiographic measurements were
performed with General Electric system VIVED 7 ma-
chine ultrasound phased array system using a 3.0-mHz
transducer for two-dimensional M-mode measurements
of the left ventricular structure and systolic function
according to the recommendations of the American
Society of Echocardiography [21].
Measurements were recorded as average of three cardiac
cycles. Left atrium (LA) dimension, left ventricular end-
systolic (LVESD) and end-diastolic dimensions (LVEDD),
diastolic ventricular septal thickness and diastolic LV
posterior wall thickness were measured in the parasternal
long-axis view. Left ventricular EF was estimated using the
Simpson’s rule. Left ventricular mass was calculated with
the Devereux equation [22] and was indexed to body
surface area (BSA).
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Left ventricular diastolic function was assessed by meas-
uring the mitral flow velocity recorded in the apical four--
chamber view. The pulse Doppler sample volume was
placed in the left ventricular inflow tract at the level of mi-
tral leaflet tips and three consecutive measurements were
averaged. The various variables of diastolic function that
were measured included: peak early (E; m/sec) and peak
atrial filling velocity (A; m/s), ratio of E to A (E/A), E ac-
celeration time, E deceleration time (Edt; m/s), isovolumic
relaxation time (IVRT) was measured in the apical five
chamber view with the sample volume placed between the
aorta and mitral valve where the recordings of both valves
were taken simultaneously.
Pulsed wave-tissue Doppler measurements
Tissue Doppler echocardiography was performed with a
concurrent Electrocardiography (ECG) recording using
Fukuda Denshi FCP-7101 Interpretive ECG Machine.
The frequency of the transducer was of 3.5–4.0 MHz,
adjusting the spectral pulsed Doppler signal filters to
obtain the Nyquist limit of 15–20 cm/sec, and using the
minimal optimal gain setting. The monitor sweep speed
was set at 50–100 mm/sec to optimize the spectral
display of myocardial velocities. A sample volume
(2 mm) was placed within mitral annulus septal myocar-
dial wall, analyzing wall motion parallel to cursor orien-
tation. Septal annulus now is the preferred site for tissue
Doppler imaging, because this location is less influenced
by the pericardium. Systolic (Sm), early diastolic (Em)
and late diastolic (Am) TD velocities were measured,
and the Em/Am ratio and the dimensionless parameter
E/Em were computed. E/Em was found in previous
studies to be directly correlated with impaired diastolic
function [23–25].
Atrial electromechanical coupling
In apical four-chamber view, the pulsed Doppler sample
volume was placed at the level of the LV lateral mitral
annulus, and subsequently at the septal mitral annulus
and right ventricular tricuspid annulus. The sampling
window was positioned as parallel as possible with the
myocardial segment of interest to obtain the optimal
angle of imaging. Atrial electromechanical coupling was
defined as the time interval from the onset of P wave on
the surface electrocardiogram to the beginning of the
late diastolic wave (Am wave), i.e. PA interval and was
measured from the lateral mitral annulus (PA lateral),
septal mitral annulus (PA septum), and right ventricular
tricuspid annulus (PA tricuspid) [9]. All PA intervals
were averaged over three consecutive beats. The dif-
ference between the lateral and tricuspid PA intervals
was defined as interatrial electromechanical delay, and
the difference between the septal and tricuspid PA
intervals was defined as intra-atrial electromechanical
delay [9].
PA lateral‐PA tricuspid msecð Þ
¼ inter‐atrial electromechanical delay;
PA septum‐PA tricuspid msecð Þ
¼ intra‐atrial electromechanical delay:
Assessment of left atrial mechanical functions
Left atrial volumes were measured by the method of
discs in the apical four-chamber view at end-systole
(maximal, Vmax), end-diastole (minimal, Vmin) and at
the onset of atrial systole (P wave on electrocardiogram,
Vp). All volumes were indexed to BSA and expressed in
ml/m2. Then, the following LA emptying function
parameters were calculated [22]:
LA passive emptying volume ¼ Vmax‐Vp;
LA passive emptying fraction ¼ Vmax‐Vpð Þ=Vmax;
LA active emptying volume ¼ Vp‐Vmin;
LA active emptying fraction ¼ Vp‐Vminð Þ=Vp;
Conduit volume ¼ LV stroke volume‐ Vmax‐Vminð Þ½ ;
and LA total emptying volume ¼ Vmax‐Vmin:
Statistical analysis
All statistical analyses were performed using the IBM
SPSS for Windows version 22.0 (SPSS Armonk, NY:
IBM Corp USA). Data were expressed as mean and
standard deviation. Student’s t test (two-tailed) was used
for inter-group comparisons. To analyze categorical
data, chi-square test was used. Nonparametric data were
analyzed using Mann Whitney U test. Pearson correl-
ation coefficient test was used to assess the degree of as-
sociation between different variables. Pearson correlation
was used to correlate continuous variables. P values
were adjusted using false discovery rate (FDR) algorithm.
Multivariate linear regression analysis was used to iden-
tify significant determinants of interatrial and intra-atrial
electromechanical delay. A p value of less than 0.05 was
considered significant.
Results
Clinical and laboratory characteristics of the two groups
are shown in Table 1. Owing to the fact that the most
prevailing presentation was the poly-articular JIA
(91.2%) and to avoid outlier we excluded the results of
patients with systemic and oligo-articular JIA (3
patients) from the analyses. Age, sex, body mass index,
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systolic and diastolic blood pressure, and heart rate,
were similar between the two groups (p > 0.05).
Patients with JIA exhibited significantly higher levels of
ESR and C reactive protein (CRP). All patients exhibited
active disease, the mean JADAS-27 score was 23.51 ± 9.53
and the mean disease duration was 50.24 ± 15.98 months.
Methotrexate was the mostly used disease modifying
anti-rheumatic drugs (DMARDs) (91.2%) in treating
JIA patients.
The main echocardiographic and Doppler findings in
this series of patients with JIA without clinical evidence
of cardiovascular disease were summarized in Table 2.
LV end-diastolic dimension (LVEDD), stroke volume, LV
mass index, LA dimension, ejection fraction (EF),
fractional shortening (FS) and Peak A velocity were
comparable between the two groups. Patients with JIA
showed a higher left ventricular end systolic diameter
(LVESD) (P = 0.01). Peak trans-mitral E velocity was
lower among patients with JIA. This was also echoed by
the E/A velocity ratio, which was significantly lower
among patients compared to the healthy population.
E/Em was significantly higher in patients with JIA
than in the control group (p = 0.02).
Left atrial mechanical functions
Left atrial volume measurements (Table 3). The two
groups were similar with respect to maximum LA
volume, Vp, Vmin, LA passive emptying volume and LA
active emptying volume and conduit volume (p > 0.05).
However, LA passive emptying fraction was significantly
decreased and LA active emptying fraction and LA total
emptying volume were significantly increased in JIA
patients (p = 0.01, p = 0.01, p = 0.03 respectively).
Atrial electromechanical coupling
Atrial electromechanical coupling intervals were mea-
sured from different areas by TDI (Table 4). JIA patients
had significantly prolonged PA lateral (p = 0.03), PA
septum (p = 0.02), inter-atrial (p = 0.04) and intra-atrial
(p = 0.02) electromechanical delays compared with
healthy controls.
Multivariate linear regression analysis showed that
Inter-atrial electromechanical delay was significantly
related with disease duration (p = 0.025), JADAS-27
(p = 0.045) and Systolic Blood pressure (p = 0.013)
(adjusted R2 = 0.16). Intra-atrial electromechanical
delay was related to disease duration (p = 0.003) and
JADAS-27 (p = 0.01) (adjusted R2 = 0.39). No associ-
ation was found between Intra-atrial electromechan-
ical delay and LA mechanical functions and to LV
functions in these patients.
Discussion
Solid data concerning cardiovascular risk in JIA patients
is still deficient [4]. However, evidence showed that
subclinical CV involvement in JIA can starts just after
the onset of the disease and exacerbates during the
course of the disease. All cardiac structures may be
involved with variable complications [5].
The present study showed that there was no signifi-
cant difference between the JIA patients and age and
Table 1 Clinical and laboratory characteristics of the study population
Variables Patients with




Age (years) 13.75 ± 4.36 12.55 ± 3.54 0.89
Gender
[Female, n (%)] 28(82.4%) 24(70.6%) 0.72
[Male, n (%)] 6(17.6%) 10 (29.4%)
Classification -
[Systemic, n(%)] 2 (6%)
[Polyarticular, n(%)] 31 (91.2%)
[Oligoarticular, n(%)] 1 (2.9%)







18.56 ± 4.8 17.35 ± 2.09 0.82
Systolic blood pressure
(mmHg)
103.87 ± 13.58 93.21 ± 4.18 0.72
Diastolic blood pressure
(mmHg)
65.81 ± 7.56 65.06 ± 5.46 0.84
Heart rate (beats/min) 95.9 ± 13.06 84.12 ± 13.24 0.82
Erythrocyte sedimentation
rate (mm/hr.)
32.74 ± 11.55 12.68 ± 2.34 0.01*
C-reactive protein (mg/l) 6.72 ± 2.43 3.12 ± 1.94 0.03*
Rheumatoid factor (+ve) 3 (8.8%) 0 (0%)
JADAS-27 23.51 ± 9.53 -

















RF rheumatoid factor, −ve negative, +ve positive, JADAS-27 Juvenile arthritis
disease activity score, NSAIDs non- steroidal anti-inflammatory drugs
*Statistically significant at p < 0.05 using Mann-Whitney U test; **p < 0.05
adjusted by false discovery rate (FDR) (Benjamini-Hochberg)
aall statistical analyses were performed for 31 patients with polyarticular JIA
after exclusion of oligo-articular and systemic JIA patients
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sex-matched control group in terms of heart rate, sys-
tolic and diastolic blood pressures.
Heart rate proved to be elevated within normal limits
in many studies [26–28], only one investigation showed
significant elevation of heart rate [29]. This elevation
could be linked to the inflammatory characteristic of the
disease and the associated released mediators [28, 29].
Systolic and diastolic blood pressures results were in
accordance with Oguz et al. [26], while studying 30
children and young subjects with JIA (aged 3–15 years),
and compared echocardiographic findings of the same
number of age and sex-matched controls found that
systolic and diastolic pressures were higher in the JIA
group although values remained within normal values.
Similarly, other researches confirmed the same findings
[28, 29]. These results were previously attributed to the
use of steroids and nonsteroidal anti-inflammatory drugs
in therapy, thus leading to salt and water retention [28].
However, this issue has been closely considered by Breda
et al. [30] who studied potential atherosclerotic changes
in 38 children with oligo- and polyarticular JIA. Blood
pressure was initially assessed revealing significantly
higher systolic and diastolic blood pressure in JIA group
when compared with controls. After 12 months a signifi-
cant reduction in blood pressure was observed. They
suggested that this change may be due to better
disease control.
Thus, patients with JIA need close monitoring of
blood pressure during follow up for early detection of
potential hypertension and adequate treatment [26–29].
Table 2 Echocardiographic characteristics of the study
population
Variables Patients with






41.77 ± 5.07 40.33 ± 1.83 0.27
LV End-systolic
dimension (mm)
27.97 ± 4.65 24.03 ± 2.97 0.01*
LV End-diastolic
volume (cm3)
118.48 ± 23.224 80.44 ± 22.56 0.01*
LV End-systolic
volume (cm3)
67.06 ± 6.47 35.91 ± 13.87 0.01*
Stroke volume (mL) 49.10 ± 12.79 52.42 ± 21.33 0.65
Cardiac output (L/min) 5.9 ± 8.5 5.4 ± 10.07 0.03*
Fractional shortening (%) 33.19 ± 4.09 41.03 ± 5.241 0.01*
Ejection fraction (%) 62.26 ± 5.60 71.70 ± 6.152 0.01*
LV Mass index (g/m2) 70.42 ± 12.26 71.70 ± 6.15 0.39
Septum thickness (mm) 7.22 ± 1.54 7.15 ± 0.834 0.94
Posterior wall
thickness (mm)
7.30 ± 1.16 7.39 ± 1.14 0.92
Left atrium
dimension (mm)
27.97 ± 4.65 26.82 ± 4.87 0.73
E (cm/s) 0.795 ± .0.16 0.99 ± 0.23 0.03*
A (cm/s) 0.64 ± 0.31 0.66 ± 0.21 0.6
E/A ratio 1.07 ± 0.56 1.48 ± 0.16 0.01*
Mitral deceleration
time (ms)
150.01 ± 62.54 149.30 ± 107.54 0.94
Isovolumic relaxation
time (ms)
72.91 ± 25.4 72.88 ± 9.58 0.94
LV Sm (cm/s) 0.09 ± 0.02 0.08 ± 0.02 0.36
LV Em (cm/s) 0.18 ± 0.06 0.17 ± 0.03 0.19
LV Am (cm/s) 0.19 ± 0.47 0.07 ± 0.02 0.03*
E/Em 7.58 ± 1.79 4.74 ± 1.45 0.01*
Em/Am 1.47 ± 0.64 1.87 ± 0.21 0.02*
LV MPI 69.42 ± 13.41 71.70 ± 6.152 0.47
*p < 0.05 adjusted by false discovery rate (FDR) (Benjamini-Hochberg)
asystemic onset and oligo-articular Subtypes were excluded from the analyses
Table 3 Left atrial volume measurements of the study population
Characteristics Patients with






28.74 ± 11.17 27.85 ± 9.8 0.51
Volume at the beginning
of atrial systole (ml/m2)
18.71 ± 7.63 18.15 ± 7.36 0.65
Minimal volume at
end-diastole (ml/m2)
11.19 ± 7.61 11.3 ± 5.39 0.27
Passive emptying
volume (ml/m2)
10.03 ± 4.20 9.70 ± 3.64 0.6
Passive emptying
fraction (%)
23.66 ± 9.98 35.56 ± 8.86 0.01*
Conduit volume (ml/m2) 31.55 ± 11.54 35.88 ± 22.37 0.43
Active emptying
volume (ml/m2)
7.52 ± 3.29 6.85 ± 3.43 0.65
Active emptying
fraction (%)
41.13 ± 11.54 32.37 ± 7.13 0.01*
Total emptying
volume (ml/m2)
18.04 ± 6.07 16.55 ± 5.49 0.03*
*p < 0.05 adjusted by false discovery rate (FDR) (Benjamini-Hochberg)
Table 4 Atrial electromechanical coupling findings measured by
tissue Doppler imaging
Variables Patients with




PA lateral (msec) 56.58 ± 19.79 48.27 ± 11.31 0.03*
PA septum (msec) 48.68 ± 25.03 39.06 ± 18.39 0.02*
PA tricuspid (msec) 31.77 ± 12.53 28.18 ± 12.05 0.08
PA lateral - PA
tricuspid (msec)a
23.52 ± 12.04 19.01 ± 10.486 0.04*
PA septum - PA
tricuspid (msec)b
17.02 ± 15.24 10.88 ± 13.610 0.02*
PA the interval with tissue Doppler imaging, from the onset of P wave on the
surface electrocardiogram to the beginning of the late diastolic wave
(Am wave)
*p < 0.05 adjusted by false discovery rate (FDR) (Benjamini-Hochberg)
aInteratrial electromechanical delays
bintra-atrial electromechanical delays
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Conduction system disorders, especially atrial fibrilla-
tion (AF), are evident in patients with rheumatic disor-
ders compared to healthy population as reported from
literature [31]. In our study, atrial electromechanical
delay was evaluated by means of tissue Doppler echocar-
diography with simultaneous ECG recording. We found
that JIA patients had significantly prolonged PA lateral,
inter-atrial and intra-atrial electromechanical delays
compared with healthy controls. These abnormalities are
usually associated with a higher risk for AF [11].
On the contrary, one research studied atrial conduction
abnormalities through measuring P wave dispersion
(PWD) and P wave duration and found that PWD value
was similar in JIA patients and healthy children [32]. They
suggested that in relation of PWD patients with JIA are
not prone to atrial arrhythmias. We attribute this variation
in results to the different methodology used in our study
as we used TDI with simultaneous ECG recording instead
of the standard ECG alone.
Our results revealed significant increase in LVESD.
Systolic function parameters (EF and FS) were lower
compared to controls but within normal limits. Several
studies were in harmony with our results, where they
reported significant higher LVESD and LVEDD [29] or
higher LVESD and lower EF compared to controls [26].
Additionally, Koca et al. [27], did not demonstrate any sig-
nificant differences in the LVESD, LVEDD, EF and FS.
Even though within normal range, increased resting heart
rate and diastolic LV dimensions together with decreased
EF and FS in JIA patients compared to healthy controls,
may be an indicator of subclinical myocarditis [14].
By analyzing the measurements of the Pulsed Wave-
Tissue Doppler, they revealed abnormalities in diastolic
function. Peak trans-mitral E velocity and E/A velocity
ratio was significantly lower among JIA patients com-
pared to the healthy group which supports diastolic
dysfunction. Our data are consistent with the data of
many studies [14, 28, 29, 33].
Concerning TDI, our results showed that E/Em, was
significantly higher and Em/Am ratio was significantly
lower in JIA patients than in control group. Alkady et al.
[28] have observed that the mitral A wave and the isovo-
lumic relaxation time were higher compared to control
group, while the mitral E wave and the E/A ratio were
found to be lower. Moreover, other study found that,
among TDI parameters, mitral annular early diastolic
velocity (Em), Em/Am ratio, E wave velocity trace inte-
gral (E VTI) and A velocity trace integral (A VTI) were
found to be lower in active JIA patients than in the
control group which support diastolic dysfunctions in
active JIA patients [14].
Diastolic dysfunction is associated with long disease
duration, but its etiology is still unclear [34]. Some
researchers had explained that these abnormalities could
hypothetically be due to an increase in afterload, a
decrease in preload or weakened relaxation of the left
ventricle, probably due to a myocardial fibrotic process
[27]. However, diastolic dysfunction may be also related
to a transient myositis or other inflammatory disease
manifestation and may have no bearing on future cardio-
vascular risk [4]. Left atrial mechanical function is an
important determinant of LV filling. Left atrial mechan-
ical functions consist of several functions at different
stages of cardiac cycle including reservoir, channel and
booster pump functions. In case of LV dysfunction, the
left atrium could maintain sufficient cardiac output by
regulation of these functions [35].
In our work, we found that, LA mechanical functions
were significantly impaired as LA passive emptying
fraction was significantly decreased while LA active
emptying fraction and LA total emptying volume were
significantly increased in JIA patients.
To our knowledge, LA mechanical functions was not
assessed in JIA. However, other studies have reported
LA impaired mechanical functions measured with TDI
in other rheumatic disease, as in patients with asymp-
tomatic scleroderma [36].
Furthermore, in order to achieve our aim, atrial elec-
tromechanical delay (AEMD) was correlated to LA
mechanical functions, LV functions and disease activity
in JIA patients. Multivariate linear regression analysis
showed that Inter-atrial electromechanical delay was sig-
nificantly correlated with disease duration, JADAS-27
and Systolic Blood pressure but this correlation showed
weak linear relationship (adjusted R2 = 0.16). Intra-atrial
electromechanical delay showed significant correlation
to disease duration and JADAS-27 and this correlation
showed strong linear relationship (adjusted R2 = 0.39).
These results indicated that cardiac damage is most
probably caused by long-term chronic inflammation and
high disease activity. Similarly, results of a study carried
out on adult RA patients, suggested that intra- and
interatrial electromechanical delays are prolonged in RA
patients, and that LA active emptying fraction and
serum CRP level are independent factors of the inter-
atrial electromechanical delay [11].
Finally, we have to take into consideration medications
used in JIA as they may also adversely affect a patient’s
cardiac condition [37]. For example, chloroquine has
cardio-toxic side effects [38] while, Sulphasalazine,
Methotrexate, Nonsteroidal Anti-inflammatory Drugs
and Steroids do not have known direct cardio-toxic side
effects. However, prolonged use of steroids predisposes
the patients to increased risk of hypertension [39] and
cardiac events [40]. Medications used by our patients
were described in Table 1, where most of them were
treated with Methotrexate (MTX). Only four patients
were on low dose steroid (<10 mg/day) and nine patients
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had a past history of steroid intake either low dose oral
steroids or local joints steroid injections, ensuring that
our findings are not related to medications side effects.
Conclusion
In conclusion, intra- and interatrial electromechanical
delays are prolonged and LA mechanical functions are
impaired in active JIA patients. So, it may be an early
form of subclinical cardiac involvement in JIA patients
with no clinical evidence for cardiovascular affection.
Disease duration and disease activity are independent
factors of the intra-atrial electromechanical delay. In
addition, our results, suggests that significant diastolic
functional abnormalities exist in JIA children.
Clinical implications
Cardiac evaluation for JIA patient should be included in
the routine follow for those patients especially blood
pressure monitoring. TDI is considered a valuable method
for assessment of subclinical cardiac involvement.
Study limitations
We acknowledge some limitations in the present study.
First small sample size and selection bias of cases being all
active JIA which hampers the generalization of the results.
Second, the cross sectional study gives a potential associ-
ation between the exposure and the outcome, not caus-
ation so longitudinal analyses (cohort study) would be
reasonable to assess the long-term effect of the disease on
the heart which is essential in summing up a final conclu-
sion. Third, there are some unmeasured confounders as
socioeconomic status and adherence to treatment.
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score; JIA: Juvenile idiopathic arthritis; LA: Left atrial; LV: Left ventricular;
LVEDD: Left ventricular end diastolic diameter; LVESD: Left ventricular end
systolic diameter; PA lateral: Lateral mitral annulus; PA septum: Septal mitral
annulus; PA tricuspid: Right ventricular tricuspid annulus; PWD: Pulse Wave
Doppler; RF -ve: Negative rheumatoid factor; Sm: Systolic velocity; TDI: Tissue
Doppler imaging; TDI: Tissue Doppler imaging; TTE: Transthoracic
echocardiographic; VAS: Visual analog scale
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